The FDA on Friday, July 13, joined more than 20 other countries in recalling medications containing valsartan, an active ingredient used to treat hypertension and heart failure. Some of the medications with valsartan have been contaminated with N-nitrosodimethylamine (NDMA), a probable human carcinogen.

The average blood pressure of American youths is declining, a new CDC report suggests, even as updated guidelines classify almost 800,000 more of them as hypertensive.

A tuberculosis vaccine that has been around for a century is being investigated as a potential low-cost, long-term treatment for type 1 diabetes.

Adoption of the new 2017 American College of Cardiology/American Heart Association (ACC/AHA) hypertension guidelines would result in a “substantial” increase in the prevalence of hypertension in both the U.S. and China.

A team of researchers used genome editing to inactivate the PCSK9 protein in the livers of rhesus macaque monkeys, resulting in 30 to 60 percent reductions in LDL cholesterol and even more significant drops in PCSK9 levels.

A new study published in the European Heart Journal suggests a particular quality of LDL cholesterol—not just the concentration of it—influences a patient’s risk of cardiovascular disease.

A program designed to help hypertensive patients with complex medication regimens understand the drugs they are prescribed not only failed to improve adherence, but it actually raised their blood pressure.

Black men and women have higher incidences of hypertension by the age of 55 compared to white men and women, according to a study published July 11 in the Journal of the American Heart Association.